About Silver bullet therapeutics
Silver Bullet Therapeutics: Revolutionizing the Fight Against Surgical-Site Infections
Silver Bullet Therapeutics is a privately held company based in San Jose, California that has developed and patented antimicrobial coating processes, implants, and medical devices to address surgical-site infections (SSIs) and hospital-acquired infections (HAIs). The company's mission is to revolutionize the fight against SSIs by providing innovative solutions that are effective, safe, and affordable.
Surgical-site infections are one of the most common complications of surgery. They occur when bacteria or other microorganisms enter the surgical site during or after surgery. These infections can cause serious complications such as sepsis, organ failure, and even death. Hospital-acquired infections are also a major problem in healthcare facilities worldwide. They can be caused by a variety of pathogens including bacteria, viruses, fungi, and parasites.
Silver Bullet Therapeutics' first commercial product is the OrthoFuzIon Bone Screw System which utilizes an advanced silver ion technology that allows for rapid and sustained ionization of silver creating an antimicrobial zone around the screw to prevent infection. This innovative technology has been shown to be highly effective in preventing SSIs caused by Staphylococcus aureus (MRSA), Escherichia coli (E.coli), Pseudomonas aeruginosa (P.aeruginosa), Klebsiella pneumoniae (K.pneumoniae) among others.
The OrthoFuzIon Bone Screw System is designed for use in orthopedic surgeries such as spinal fusion procedures where screws are used to stabilize bones during healing. The system consists of bone screws coated with a proprietary silver-based material that releases antimicrobial ions into surrounding tissues over time. This creates an environment hostile to bacterial growth while promoting bone healing.
The OrthoFuzIon Bone Screw System has been extensively tested both in vitro and in vivo with excellent results. In vitro studies have shown that the system is effective against a wide range of bacteria and fungi, including antibiotic-resistant strains. In vivo studies have demonstrated that the system reduces the incidence of SSIs by up to 90% compared to traditional bone screws.
Silver Bullet Therapeutics is committed to developing innovative solutions for preventing SSIs and HAIs. The company's research and development team is constantly working on new products and technologies that can help reduce the incidence of these infections in healthcare facilities worldwide.
In addition to its OrthoFuzIon Bone Screw System, Silver Bullet Therapeutics has also developed other medical devices such as catheters, implants, and wound dressings that utilize its proprietary silver-based technology. These products are currently undergoing clinical trials with promising results.
Silver Bullet Therapeutics' commitment to innovation, safety, and affordability has made it a leader in the fight against SSIs. Its OrthoFuzIon Bone Screw System has already been adopted by many leading hospitals worldwide as a standard of care for orthopedic surgeries. With its continued focus on research and development, Silver Bullet Therapeutics is poised to make even greater strides in preventing SSIs in the years ahead.
svbtx.com